{"id":243382,"date":"2026-08-30T02:03:15","date_gmt":"2026-08-30T07:03:15","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/08\/cancer-breakthrough-personalized-vaccine-passes-phase-3-trial"},"modified":"2026-08-30T02:03:15","modified_gmt":"2026-08-30T07:03:15","slug":"cancer-breakthrough-personalized-vaccine-passes-phase-3-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/08\/cancer-breakthrough-personalized-vaccine-passes-phase-3-trial","title":{"rendered":"Cancer BREAKTHROUGH: Personalized Vaccine Passes Phase 3 Trial"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/Z9BJb8lS1lo?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>A cancer vaccine built from a patient\u2019s own tumor just passed a Phase 3 trial, the first time that has ever happened. Moderna and Merck\u2019s intismeran autogene (mRNA-4157 \/ V940) reads the DNA of a patient\u2019s melanoma, picks up to 34 tumor-specific mutations, and writes them into a single strand of mRNA that trains the immune system to hunt the cancer. Combined with Keytruda, it kept melanoma from coming back or spreading in a 1,137 patient trial. Moderna\u2019s stock jumped over 200 percent in a day.<\/p>\n<p>In this episode: what was actually announced (and the numbers that weren\u2019t), how the 130-year-old idea behind it finally worked, why the mRNA backlash aimed at the wrong suspect, a beat-by-beat check on the viral claims (\\.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A cancer vaccine built from a patient\u2019s own tumor just passed a Phase 3 trial, the first time that has ever happened. Moderna and Merck\u2019s intismeran autogene (mRNA-4157 \/ V940) reads the DNA of a patient\u2019s melanoma, picks up to 34 tumor-specific mutations, and writes them into a single strand of mRNA that trains the [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1522],"tags":[],"class_list":["post-243382","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-innovation"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/243382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=243382"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/243382\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=243382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=243382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=243382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}